Navigation Links
Acute Ischemic Stroke Drug Market Will Remain Relatively Flat, Increasing From $360 Million in 2008 to $450 Million in 2018
Date:11/17/2009

WALTHAM, Mass., Nov. 17 /PRNewswire/ -- Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds that sales of agents to treat acute ischemic stroke will remain relatively flat over the next decade, increasing from $360 million in 2008 to $450 million in 2018 in the United States, France, Germany, Italy, Spain, the United Kingdom and Japan.

The new Pharmacor report entitled Acute Ischemic Stroke finds that broadening the use of the recombinant tissue plasminogen activator (rt-PA; Genentech's Activase, other brands) and innovative therapies like stroke devices, such as Concentric Medical's Merci Retrieval System, will be important near-term advancements in the treatment of this indication. According to the report, drug-treatment rates for acute ischemic stroke will fluctuate modestly as the use of thrombolysis gradually increases, aided by continued improvements in stroke care throughout the major pharmaceutical markets.

Activase is now recommended for intravenous administration within 4.5 hours of stroke onset , as a result of recent positive clinical trial results from the third European Cooperative Acute Stroke Study (ECASS III). The report finds that the slowly expanding use of Activase will contribute to a modestly growing market through 2018, but a variety of limiting factors will continue to constrain the adoption of this and other time-sensitive treatments, and the promise of emerging therapies for acute ischemic stroke remains highly uncertain.

"In light of the recent discontinuations of several clinical-stage products, the stroke market continues to be a graveyard for drug development," said Decision Resources Analyst Jonathan Searles, B.A. "While drug developers continue to investigate novel therapies to expand the stroke armamentarium, interviewed experts express their lingering doubts about the clinical potential of late-stage compo
'/>"/>

SOURCE Decision Resources
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Xenomics Announces Implementation of its First Diagnostic Test for Acute Myeloid Leukemia Into Clinical Practice
2. TorreyPines Therapeutics Completes Patient Enrollment in Phase IIb Clinical Trial of Tezampanel for the Treatment of Acute Migraine Headache
3. Quark Pharmaceuticals, Inc. Presented Positive Preclinical Results of Systemic RNAi Compound for Acute Renal Failure (ARF)
4. Quark Pharmaceuticals Extends Research Agreement with State University of New York for Proprietary siRNA Compounds for Acute Hearing Loss
5. Biopure Seeks Compassionate Use Protocol for Treatment of Acute Anemia
6. CuraGen and TopoTarget Initiate Phase I/II Clinical Trial of Belinostat (PXD101) Combination Therapy for Acute Myeloid Leukemia
7. Alseres Pharmaceuticals Announces Expansion of the Cethrin(R) Acute Spinal Cord Injury (SCI) Phase I/IIA Clinical Trial
8. Analysis Shows Vernakalant Hydrochloride Injection Increases Conversion to Normal Heart Rhythm in Acute Atrial Fibrillation Patients Treated Within 48 Hours of Onset
9. INVEGA(TM) Significantly Reduced Symptoms of Schizophrenia Compared to SEROQUEL(R) in Acutely Ill, Hospitalized Patients
10. Plavix(R) Indications Expanded in Japan to Include Patients with Acute Coronary Syndrome for Whom Percutaneous Coronary Intervention Is Being Planned
11. Tezampanel Meets Primary Endpoint in Phase IIb Clinical Trial in Acute Migraine Headache
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/4/2015)... May 4, 2015  NeuroSigma ® , Inc. (NeuroSigma), a ... results of an animal study of its Thin Film Nitinol ... by Mayo Clinic researchers at the 53 rd Annual ... Chicago, Illinois . A copy of the study abstract ... The study at Mayo Clinic was primarily funded through ...
(Date:5/4/2015)... 2015 Dynatronics Corporation (the "Company") (NASDAQ: ... rehabilitation and physical therapy products, announced today that ... approximately $4,000,000 in a private placement financing led ... affiliates (together with its affiliates, "Prettybrook"), a strategic ... The financing will provide Dynatronics with additional capital ...
(Date:5/4/2015)... 2015   Mallinckrodt plc (NYSE: MNK ), ... 13, 2015, at the Bank of America Merrill Lynch 2015 ... Las Vegas, Nev. ... Officer, and Cole Lannum , Senior Vice President of ... in a session scheduled to begin at 3 p.m. Eastern ...
Breaking Medicine Technology:NeuroSigma's Thin Film Nitinol Flow Diverting Stent Results Presented at the American Society of Neuroradiology Meeting 2NeuroSigma's Thin Film Nitinol Flow Diverting Stent Results Presented at the American Society of Neuroradiology Meeting 3NeuroSigma's Thin Film Nitinol Flow Diverting Stent Results Presented at the American Society of Neuroradiology Meeting 4Dynatronics Announces $4,000,000 Private Placement Led By Prettybrook Partners 2Dynatronics Announces $4,000,000 Private Placement Led By Prettybrook Partners 3Dynatronics Announces $4,000,000 Private Placement Led By Prettybrook Partners 4Mallinckrodt To Present At Bank Of America Merrill Lynch 2015 Health Care Conference 2
... 04, 2007 /PRNewswire/ -- GlaxoSmithKline today,announced results ... in,advanced or metastatic renal cell carcinoma (RCC), ... trials were presented at the,43rd Annual Meeting ... in Chicago. The results observed in these ...
... Calif., June 04, 2007 /PRNewswire/ -- (SEND2PRESS,NEWSWIRE) -- ... historic landmark in medical oncology and a,definitive benchmark ... first clinical report of its kind, Le Morte ... the International Journal of,Oncology, Vol.30, pp. 1297-1307 -- ...
Cached Medicine Technology:GSK'S Pazopanib Shows Positive Results in Patients with Advanced,Renal Cell Carcinoma, Ovarian Cancer and Soft Tissue Sarcoma 2GSK'S Pazopanib Shows Positive Results in Patients with Advanced,Renal Cell Carcinoma, Ovarian Cancer and Soft Tissue Sarcoma 3GSK'S Pazopanib Shows Positive Results in Patients with Advanced,Renal Cell Carcinoma, Ovarian Cancer and Soft Tissue Sarcoma 4GSK'S Pazopanib Shows Positive Results in Patients with Advanced,Renal Cell Carcinoma, Ovarian Cancer and Soft Tissue Sarcoma 5GSK'S Pazopanib Shows Positive Results in Patients with Advanced,Renal Cell Carcinoma, Ovarian Cancer and Soft Tissue Sarcoma 6GSK'S Pazopanib Shows Positive Results in Patients with Advanced,Renal Cell Carcinoma, Ovarian Cancer and Soft Tissue Sarcoma 7News from the Battlefield of Metastatic Cancer: Epeius,Biotechnologies Draws the Sword of Targeted Gene Delivery (Rexin-G),from the Stone of Chemistry and Physics 2News from the Battlefield of Metastatic Cancer: Epeius,Biotechnologies Draws the Sword of Targeted Gene Delivery (Rexin-G),from the Stone of Chemistry and Physics 3
(Date:5/4/2015)... 2015 New West Medicare is excited ... LLC to manage outpatient advanced imaging services for its ... ensure its members are provided the right test at ... closely with New West Medicare’s physicians and hospitals, Care ... of advanced imaging and provide an objective basis for ...
(Date:5/4/2015)... Dr. Richard Champagne, DMD, MAGD is pleased ... the America’s Best Dentist Award, given by the National ... top dentist is a reflection of his vast experience ... compassion for his patients. , Each year, the National ... their field. These nominees are dentists who have exceptionally ...
(Date:5/4/2015)... May 04, 2015 World T.E.A.M. Sports’ ... cycle ride in the last decade arrived in this ... miles in two days from the Pentagon in Arlington, ... 581 registered disabled and able-bodied participants work together to ... recognizes and honors the commitment and sacrifices by military ...
(Date:5/4/2015)... Food Cost Calculator ” was featured on NewsWatch as part ... latest and coolest applications on the market for iOS, Android, ... expert, conducted the app review and shared with viewers how ... food costs. , The restaurant industry is a vital cornerstone ... estimated 1.8 trillion dollar impact on the US economy. But ...
(Date:5/4/2015)... Peacock Alley knows we all ... “My mother was the most beautiful woman I ever saw.” ... feminine prints and textures to remind her just ... the Eloise Robe to get you there. The beautiful Monet-inspired ... and tapered waist. It is available in small/medium or large/extra ...
Breaking Medicine News(10 mins):Health News:New West Medicare Partners with Care to Care, LLC to Manage Advanced Imaging Services 2Health News:New Jersey Dentist Dr. Richard Champagne Nominated for America’s Best Dentist Award 2Health News:Gettysburg Welcomes Arriving Face of America Riders with Gala Celebration 2Health News:Gettysburg Welcomes Arriving Face of America Riders with Gala Celebration 3Health News:Gettysburg Welcomes Arriving Face of America Riders with Gala Celebration 4Health News:An Application to Manage a Successful Restaurant Was Featured on NewsWatch Television 2Health News:Feminine Classics for Mother's Day Gifts from Peacock Alley 2
... Birner Dental Management,Services, Inc. (Nasdaq: ... announced results for the year ended December ... $2.2 million, or 3.9%, to $59.4,million. Net ... $40.8 million. The,Company,s earnings before interest, taxes, ...
... with dietary restrictions and personal ... ... and created,its own software program that essentially reads the labels for ... online and highlights the ones that meet customers,unique nutritional needs, whether ...
... As the April 15 tax deadline,looms, filers ... term care,insurance, according to LTC Financial Partners LLC, ... *(PHOTO 72dpi: Send2Press.com/mediaboom/07-0807-LTCTruesdell_72dpi.jpg), *(Photo Caption: LTC ... policies can deduct substantial sums," says Cameron,Truesdell, CEO ...
... SAN DIEGO, March 17 The Pharmaceutical,Research and ... with the U.S. Fish and Wildlife Service (USFWS) ... the nation,s fish and,aquatic resources from the improper ... -- will inform people on how to safely ...
... /PRNewswire/ - Organogenesis, Inc., announced,today that Damien ... the company as,vice president of medical affairs., ... Bates combines more than twelve years of ... He has practiced in,orthopedic, dermatologic, vascular, oncologic ...
... Their gentle nature, large size, odd sounds and ... tools and pets for years. But the giant insects ... feces are home to many mold species that could ... handle the bugs, according to a new study. , ...
Cached Medicine News:Health News:Birner Dental Management Services, Inc. Announces 10.0% Adjusted EBITDA Increase for 2007 Versus 2006 2Health News:Birner Dental Management Services, Inc. Announces 10.0% Adjusted EBITDA Increase for 2007 Versus 2006 3Health News:Birner Dental Management Services, Inc. Announces 10.0% Adjusted EBITDA Increase for 2007 Versus 2006 4Health News:Birner Dental Management Services, Inc. Announces 10.0% Adjusted EBITDA Increase for 2007 Versus 2006 5Health News:Birner Dental Management Services, Inc. Announces 10.0% Adjusted EBITDA Increase for 2007 Versus 2006 6Health News:Birner Dental Management Services, Inc. Announces 10.0% Adjusted EBITDA Increase for 2007 Versus 2006 7Health News:Birner Dental Management Services, Inc. Announces 10.0% Adjusted EBITDA Increase for 2007 Versus 2006 8Health News:Peapod Offers First Ever Virtual Nutritionist 2Health News:TAX ALERT: Deductions for Long Term Care Insurance Premiums 2Health News:Medicine Disposal Partnership Will Encourage Public to Flush Less, Crush More 2Health News:Medicine Disposal Partnership Will Encourage Public to Flush Less, Crush More 3Health News:Organogenesis Names Regenerative Medicine Expert Dr. Damien Bates Vice President, Medical Affairs 2Health News:Organogenesis Names Regenerative Medicine Expert Dr. Damien Bates Vice President, Medical Affairs 3Health News:Hissing cockroaches are popular, but they also host potent mold allergens 2
The Snap-In Snap-Out-II Tip Inserts offer a large variety of configurations....
This is a single-action instrument that features a spring handle....
The Snap-In Snap-Out-II Tip Inserts offer a large variety of configurations....
The Snap-In Snap-Out-II Tip Inserts offer a large variety of configurations....
Medicine Products: